Page 1 of 112
NR565 ADVANCED PHARMACOLOGY EXAM LATEST
VERSION QUESTIONS AND ANSWERS 2026 EDITION
NR565 Advanced Pharmacology - 250 Question Exam Bank
SECTION 1: PRESCRIPTIVE AUTHORITY, LEGAL & ETHICAL FRAMEWORKS
(Questions 1-25)
Question 1
A nurse practitioner preparing to prescribe controlled substances for patients in an
outpatient clinic must understand that the legal authority to prescribe medications is
primarily governed by which entity, and why does this create variability in practice
across different jurisdictions?
A) The federal Drug Enforcement Administration, because it establishes uniform
national prescribing standards for all healthcare providers
B) State boards of nursing, medicine, and pharmacy operating under state statutes, as
the federal government regulates drug scheduling but not prescriptive authority
C) The Food and Drug Administration, because it determines which drugs can be
marketed and prescribed in the United States
D) The Centers for Medicare and Medicaid Services, since reimbursement requirements
effectively determine prescribing parameters
Answer: B
Rationale: Prescriptive authority is governed by state laws under the jurisdiction of
state health professional boards (nursing, medicine, pharmacy). The federal
government regulates drug scheduling and controlled substance classification but does
not control who can prescribe. This state-level governance creates variability in APRN
practice authority across jurisdictions .
, Page 2 of 112
Question 2
A newly licensed nurse practitioner is determining whether they can prescribe Schedule
II controlled substances independently in their state. What is the most accurate
statement regarding full practice authority and its relationship to controlled substance
prescribing?
A) Full practice authority is granted by the DEA and allows independent prescribing of all
controlled substances without state oversight
B) Full practice authority means no physician oversight is legally required for
prescribing, though individual states may still impose restrictions on controlled
substance categories
C) Full practice authority applies only to non-controlled medications, while Schedule II-
V substances always require collaborative physician agreements
D) Full practice authority is determined by hospital privileging committees rather than
state regulatory boards
Answer: B
Rationale: Full, independent prescriptive authority occurs when no physician oversight
is legally required. However, even in full practice authority states, individual states may
impose restrictions on specific drug classes or require additional DEA registration. The
state determines the practice level, not the federal government .
Question 3
A nurse practitioner is completing a prescription for a Schedule II controlled substance
for a patient with chronic pain. According to DEA regulations, which elements must be
present on this prescription to be considered valid, and what quantity limitations apply?
A) The prescription must include the patient's name and address, drug name and
strength, and may include up to five refills within a six-month period
B) The prescription must contain the date of issue, patient name and address,
clinician's name and DEA number, drug name and strength, with limits on refills and
quantity prescribed
C) The prescription requires only the patient's name and the drug name, with refill
information documented separately in the medical record
D) The prescription must be handwritten on tamper-resistant paper and cannot be
transmitted electronically under any circumstances
Answer: B
Rationale: DEA regulations require Schedule II prescriptions to include: date of issue,
patient name/address/DOB, clinician name/address/DEA number, drug
name/strength/form/quantity. Quantity and refill limits apply; Schedule II drugs cannot
be refilled and require a new prescription each time .
, Page 3 of 112
Question 4
A nurse practitioner is utilizing the state Prescription Drug Monitoring Program (PDMP)
before prescribing an opioid analgesic. What is the primary purpose of accessing this
database, and which patients should prompt mandatory review?
A) To verify insurance coverage and determine formulary status for expensive pain
medications before prescribing
B) To identify patients who may be receiving controlled substances from multiple
prescribers and to detect potential misuse or diversion patterns
C) To confirm that the patient has tried non-pharmacological pain management
strategies before initiating opioid therapy
D) To determine if the patient has a history of substance abuse treatment that would
contraindicate opioid prescribing
Answer: B
Rationale: PDMP databases are designed to track controlled substance prescriptions
across prescribers and pharmacies. They help identify patients receiving medications
from multiple sources, detect potential misuse or diversion, and inform clinical
decision-making about prescribing controlled substances .
Question 5
A nurse practitioner is explaining the benefits of electronic prescribing to a colleague
who prefers written prescriptions. Which statement accurately describes a key
advantage of e-prescribing for controlled substances in the context of patient safety
and regulatory compliance?
A) E-prescribing eliminates the need for DEA registration because electronic signatures
are considered equivalent to federal authorization
B) E-prescribing reduces medication errors, allows for real-time drug interaction
checking, and enables direct submission to pharmacies while maintaining secure
prescribing records
C) E-prescribing automatically overrides state-specific prescribing restrictions, creating
uniformity across all jurisdictions
D) E-prescribing allows for unlimited refills of Schedule II medications without requiring
a new prescription each time
Answer: B
Rationale: E-prescribing reduces medication errors through electronic verification,
provides real-time drug interaction alerts, enables direct pharmacy submission to
, Page 4 of 112
prevent prescription loss or alteration, and maintains secure prescribing records. It
does not eliminate DEA requirements or override state restrictions .
Question 6
A nurse practitioner is reviewing their state's requirements for APRN prescriptive
authority. Which statement accurately describes the relationship between federal drug
scheduling and state-level prescribing authority for controlled substances?
A) The federal DEA schedule determines both the substance's legal classification and
the specific prescribers authorized to prescribe each schedule
B) States may impose additional restrictions on prescribing controlled substances but
cannot authorize prescribing of substances that the DEA has placed in Schedule I
C) State boards have authority to reclassify drugs to different schedules based on local
public health needs, overriding federal classifications
D) The FDA classification system supersedes DEA scheduling for determining
prescriptive authority of nurse practitioners
Answer: B
Rationale: The DEA establishes federal drug schedules based on abuse potential and
medical use. States may impose additional restrictions (e.g., requiring special
registration, limiting quantities) but cannot authorize prescribing of Schedule I
substances (no accepted medical use). States cannot reclassify drugs to lower
schedules .
Question 7
A nurse practitioner is considering the impact of the BEERS Criteria on prescribing for
an 82-year-old patient with multiple chronic conditions. What is the primary purpose of
these criteria, and which medication classes are typically identified as potentially
inappropriate?
A) The BEERS Criteria identify medications that should be prioritized for use in older
adults based on their favorable safety profiles and efficacy data
B) The BEERS Criteria identify potentially inappropriate medications for older adults
based on risk-benefit analysis, considering adverse effects and safer alternatives
C) The BEERS Criteria establish mandatory prescribing restrictions that all providers
must follow when treating patients over age 75
D) The BEERS Criteria focus exclusively on cardiovascular medications and their
interactions with age-related physiological changes
Answer: B
Rationale: The BEERS Criteria identify medications that are potentially inappropriate for
NR565 ADVANCED PHARMACOLOGY EXAM LATEST
VERSION QUESTIONS AND ANSWERS 2026 EDITION
NR565 Advanced Pharmacology - 250 Question Exam Bank
SECTION 1: PRESCRIPTIVE AUTHORITY, LEGAL & ETHICAL FRAMEWORKS
(Questions 1-25)
Question 1
A nurse practitioner preparing to prescribe controlled substances for patients in an
outpatient clinic must understand that the legal authority to prescribe medications is
primarily governed by which entity, and why does this create variability in practice
across different jurisdictions?
A) The federal Drug Enforcement Administration, because it establishes uniform
national prescribing standards for all healthcare providers
B) State boards of nursing, medicine, and pharmacy operating under state statutes, as
the federal government regulates drug scheduling but not prescriptive authority
C) The Food and Drug Administration, because it determines which drugs can be
marketed and prescribed in the United States
D) The Centers for Medicare and Medicaid Services, since reimbursement requirements
effectively determine prescribing parameters
Answer: B
Rationale: Prescriptive authority is governed by state laws under the jurisdiction of
state health professional boards (nursing, medicine, pharmacy). The federal
government regulates drug scheduling and controlled substance classification but does
not control who can prescribe. This state-level governance creates variability in APRN
practice authority across jurisdictions .
, Page 2 of 112
Question 2
A newly licensed nurse practitioner is determining whether they can prescribe Schedule
II controlled substances independently in their state. What is the most accurate
statement regarding full practice authority and its relationship to controlled substance
prescribing?
A) Full practice authority is granted by the DEA and allows independent prescribing of all
controlled substances without state oversight
B) Full practice authority means no physician oversight is legally required for
prescribing, though individual states may still impose restrictions on controlled
substance categories
C) Full practice authority applies only to non-controlled medications, while Schedule II-
V substances always require collaborative physician agreements
D) Full practice authority is determined by hospital privileging committees rather than
state regulatory boards
Answer: B
Rationale: Full, independent prescriptive authority occurs when no physician oversight
is legally required. However, even in full practice authority states, individual states may
impose restrictions on specific drug classes or require additional DEA registration. The
state determines the practice level, not the federal government .
Question 3
A nurse practitioner is completing a prescription for a Schedule II controlled substance
for a patient with chronic pain. According to DEA regulations, which elements must be
present on this prescription to be considered valid, and what quantity limitations apply?
A) The prescription must include the patient's name and address, drug name and
strength, and may include up to five refills within a six-month period
B) The prescription must contain the date of issue, patient name and address,
clinician's name and DEA number, drug name and strength, with limits on refills and
quantity prescribed
C) The prescription requires only the patient's name and the drug name, with refill
information documented separately in the medical record
D) The prescription must be handwritten on tamper-resistant paper and cannot be
transmitted electronically under any circumstances
Answer: B
Rationale: DEA regulations require Schedule II prescriptions to include: date of issue,
patient name/address/DOB, clinician name/address/DEA number, drug
name/strength/form/quantity. Quantity and refill limits apply; Schedule II drugs cannot
be refilled and require a new prescription each time .
, Page 3 of 112
Question 4
A nurse practitioner is utilizing the state Prescription Drug Monitoring Program (PDMP)
before prescribing an opioid analgesic. What is the primary purpose of accessing this
database, and which patients should prompt mandatory review?
A) To verify insurance coverage and determine formulary status for expensive pain
medications before prescribing
B) To identify patients who may be receiving controlled substances from multiple
prescribers and to detect potential misuse or diversion patterns
C) To confirm that the patient has tried non-pharmacological pain management
strategies before initiating opioid therapy
D) To determine if the patient has a history of substance abuse treatment that would
contraindicate opioid prescribing
Answer: B
Rationale: PDMP databases are designed to track controlled substance prescriptions
across prescribers and pharmacies. They help identify patients receiving medications
from multiple sources, detect potential misuse or diversion, and inform clinical
decision-making about prescribing controlled substances .
Question 5
A nurse practitioner is explaining the benefits of electronic prescribing to a colleague
who prefers written prescriptions. Which statement accurately describes a key
advantage of e-prescribing for controlled substances in the context of patient safety
and regulatory compliance?
A) E-prescribing eliminates the need for DEA registration because electronic signatures
are considered equivalent to federal authorization
B) E-prescribing reduces medication errors, allows for real-time drug interaction
checking, and enables direct submission to pharmacies while maintaining secure
prescribing records
C) E-prescribing automatically overrides state-specific prescribing restrictions, creating
uniformity across all jurisdictions
D) E-prescribing allows for unlimited refills of Schedule II medications without requiring
a new prescription each time
Answer: B
Rationale: E-prescribing reduces medication errors through electronic verification,
provides real-time drug interaction alerts, enables direct pharmacy submission to
, Page 4 of 112
prevent prescription loss or alteration, and maintains secure prescribing records. It
does not eliminate DEA requirements or override state restrictions .
Question 6
A nurse practitioner is reviewing their state's requirements for APRN prescriptive
authority. Which statement accurately describes the relationship between federal drug
scheduling and state-level prescribing authority for controlled substances?
A) The federal DEA schedule determines both the substance's legal classification and
the specific prescribers authorized to prescribe each schedule
B) States may impose additional restrictions on prescribing controlled substances but
cannot authorize prescribing of substances that the DEA has placed in Schedule I
C) State boards have authority to reclassify drugs to different schedules based on local
public health needs, overriding federal classifications
D) The FDA classification system supersedes DEA scheduling for determining
prescriptive authority of nurse practitioners
Answer: B
Rationale: The DEA establishes federal drug schedules based on abuse potential and
medical use. States may impose additional restrictions (e.g., requiring special
registration, limiting quantities) but cannot authorize prescribing of Schedule I
substances (no accepted medical use). States cannot reclassify drugs to lower
schedules .
Question 7
A nurse practitioner is considering the impact of the BEERS Criteria on prescribing for
an 82-year-old patient with multiple chronic conditions. What is the primary purpose of
these criteria, and which medication classes are typically identified as potentially
inappropriate?
A) The BEERS Criteria identify medications that should be prioritized for use in older
adults based on their favorable safety profiles and efficacy data
B) The BEERS Criteria identify potentially inappropriate medications for older adults
based on risk-benefit analysis, considering adverse effects and safer alternatives
C) The BEERS Criteria establish mandatory prescribing restrictions that all providers
must follow when treating patients over age 75
D) The BEERS Criteria focus exclusively on cardiovascular medications and their
interactions with age-related physiological changes
Answer: B
Rationale: The BEERS Criteria identify medications that are potentially inappropriate for
